Concepedia

Sergey Tereschenko

ST

Statistics

Publications

6

Citations

3.6K

H-Index

6

Active since

2009

Affiliations

University of Toronto(Current)

Semmelweis University

National Medical Research Center of Cardiology

St. Michael's Hospital

Mossakowski Medical Research Institute, Polish Academy of Sciences

Sergey Tereschenko is an author at University of Toronto specializing in medicine, diabetes, and metabolic syndrome.

Top concepts

Publications per year

2009–2024

6

Publications

6

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction

Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett et al. · JACC Heart Failure · 2022 · 155 citations · Full text

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson et al. · Diabetes Care · 2020 · 42 citations · Full text

Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE

S Leontyev, Sergey Tereschenko, I. S. Yavelov et al. · Journal of Thrombosis and Haemostasis · 2024 · 14 citations

1–5 of 6